These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9064729)

  • 1. [Current status of estrogen and gestagen substitution in peri and postmenopause].
    Birkhäuser M
    Praxis (Bern 1994); 1997 Jan; 86(5):125-8. PubMed ID: 9064729
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormone replacement therapy].
    Nozue E
    Nihon Rinsho; 1994 Mar; 52(3):787-92. PubMed ID: 8164383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of the family doctor in the complex treatment of early and late consequences of postmenopause. Effect of estrogen-progestogen on osteoporosis].
    Farkas M
    Acta Pharm Hung; 1995 May; 65(3):77-89. PubMed ID: 7572188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estrogen-gestagen substitution in geriatric gynecology. Long-term prevention for the third segment of life after menopause].
    Lauritzen C
    Fortschr Med; 1996 May; 114(15):187-90. PubMed ID: 8767936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone replacement therapy of menopause. When to begin? When to stop?].
    Tabaste JL
    Contracept Fertil Sex; 1997 Apr; 25(4):285-7. PubMed ID: 9229518
    [No Abstract]   [Full Text] [Related]  

  • 6. Rationale for later and less postmenopausal estrogen (PME).
    Barrett-Connor E
    Aging (Milano); 1998 Apr; 10(2):158. PubMed ID: 9666213
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of initial gestagen treatment on bleeding patterns in postmenopausal women receiving continuous combined hormone replacement therapy.
    Büyük E; Durmuşoğlu F; Dökmeci C
    Menopause; 1999; 6(2):156-60. PubMed ID: 10374223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global consensus statement on menopausal hormone therapy.
    de Villiers TJ; Gass ML; Haines CJ; Hall JE; Lobo RA; Pierroz DD; Rees M
    Climacteric; 2013 Apr; 16(2):203-4. PubMed ID: 23488524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommendations of the study group "Hormone substitution in postmenopause after breast cancer" of the German Society for Breast Diseases].
    Maass H; Brändle LW; von Fournier D; Lauritzen C; Schulz KD
    Zentralbl Gynakol; 1990; 112(18):1169-70. PubMed ID: 2275292
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormone therapy for the menopause.
    Gambrell RD; Greenblatt RB
    Geriatrics; 1981 Jul; 36(7):53-61. PubMed ID: 7239166
    [No Abstract]   [Full Text] [Related]  

  • 11. Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause.
    Birkhäuser MH; Panay N; Archer DF; Barlow D; Burger H; Gambacciani M; Goldstein S; Pinkerton JA; Sturdee DW
    Climacteric; 2008 Apr; 11(2):108-23. PubMed ID: 18365854
    [No Abstract]   [Full Text] [Related]  

  • 12. Postmenopausal hormone-replacement therapy, plasma lipoprotein[a], and risk for coronary heart disease.
    Gotto AM
    J Lab Clin Med; 1994 Jun; 123(6):800-3. PubMed ID: 8201254
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormone therapy: continuing discussion and debate.
    Apgar BS; Weismiller DG
    Am Fam Physician; 2003 Apr; 67(7):1444, 1446, 1449. PubMed ID: 12722847
    [No Abstract]   [Full Text] [Related]  

  • 14. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polish consensus: procedure in case of estrogen deficiency in women after breast cancer therapy.
    Milewicz A; Szymański W; Ruzyłło W; Zgliczyński S; Reinfus M; Zieliński J; Debski R; Demissie M; Tworowska U
    Gynecol Endocrinol; 2002 Oct; 16(5):385-9. PubMed ID: 12587533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estrogens in menopause--therapy and prevention. I. Hormone substitution in climacteric and postmenopause].
    Wuttke W
    Internist (Berl); 1996 Apr; 37(4):402-5. PubMed ID: 8655280
    [No Abstract]   [Full Text] [Related]  

  • 17. Current trends in hormone replacement therapy.
    Khashoggi TY
    Saudi Med J; 2002 May; 23(5):495-502. PubMed ID: 12070567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secondary prevention in coronary diseases. Viewpoint of the gynecological endocrinologist].
    Hänggi W
    Praxis (Bern 1994); 1997 Jan; 86(5):145-9. PubMed ID: 9064732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Difficult decisions on estrogen treatment of women with coronary diseases].
    al-Khalili F
    Lakartidningen; 1999 May; 96(18):2196. PubMed ID: 10377656
    [No Abstract]   [Full Text] [Related]  

  • 20. New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation.
    Sitruk-Ware R
    Climacteric; 2007 Oct; 10(5):358-70. PubMed ID: 17852138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.